Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Clin Transplant. 2019 Jun 25;33(7):e13634. doi: 10.1111/ctr.13634

Table 2 -.

Multivariable Cox Regression Model Predicting HCC Recurrence Survival

Variable Hazard Ratio 95% Confidence Interval P value
Age at transplant (per 5 years) 1.06 (1.01 – 1.11) 0.03*
MELD score (per 5 points) 1.07 (1.02 – 1.13) <0.01*
Maximum pre-transplant AFP category (ng/mL; ref ≤20)
 21–99 1.25 (1.04 – 1.50) 0.02*
 100–499 1.45 (1.20 – 1.76) <0.001*
 ≥500 1.61 (1.28 – 2.02) <0.001*
Time to HCC recurrence (per month) 0.99 (0.99 – 1.00) 0.12
Time to HCC recurrence (TVC) 1.00 (1.00 – 1.00) <0.01*

MELD = model for end-stage liver disease, AFP = alpha fetoprotein, HCC = hepatocellular carcinoma, TVC = time-varying covariate

*

p < 0.05

**

Sex and transplant region were significant on univariate analysis but not retained in multivariable models